Peptide receptor radionuclide therapy (PRRT): clinical significance of re-treatment?

被引：13

作者：

Virgolini, Irene ^{[1
]}

机构：

[1] Med Univ Innsbruck, Dept Nucl Med, A-6020 Innsbruck, Austria

来源：

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2015年 / 42卷 / 13期

关键词：

RADIOLABELED SOMATOSTATIN ANALOG; NEUROENDOCRINE TUMORS; RADIOPEPTIDE THERAPY; SALVAGE THERAPY; LU-177-OCTREOTATE; TOXICITY; CHEMOTHERAPY; OCTREOTATE; SURVIVAL; PET;

D O I：

10.1007/s00259-015-3153-z

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

[No abstract available]

引用

页码：1949 / 1954

页数：6

共 33 条

[1] 18F-Fluorodeoxyglucose Positron Emission Tomography Predicts Survival of Patients with Neuroendocrine Tumors [J].

Binderup, Tina ;

Knigge, Ulrich ;

Loft, Annika ;

Federspiel, Birgitte ;

Kjaer, Andreas .

CLINICAL CANCER RESEARCH, 2010, 16 (03) :978-985

[2] Long-term tolerability of PRRT in 807 patients with neuroendocrine tumours: the value and limitations of clinical factors [J].

Bodei, Lisa ;

Kidd, Mark ;

Paganelli, Giovanni ;

Grana, Chiara M. ;

Drozdov, Ignat ;

Cremonesi, Marta ;

Lepensky, Christopher ;

Kwekkeboom, Dik J. ;

Baum, Richard P. ;

Krenning, Eric P. ;

Modlin, Irvin M. .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 (01) :5-19

[3]

Caplin ME, 2014, NEW ENGL J MED, V371, P1556, DOI [10.1056/NEJMc1409757, 10.1056/NEJMoa1316158]

[4]

Cherry SR, 2012, PHYS NUCL MED, P73

[5]

de Jong M, 2005, J NUCL MED, V46, p13S

[6]

Forrer F, 2005, J NUCL MED, V46, P1310

[7]

Gabriel M, 2010, Q J NUCL MED MOL IM, V54, P92

[8] 68Ga-DOTA-Tyr3-Octreotide PET for Assessing Response to Somatostatin-Receptor-Mediated Radionuclide Therapy [J].

Gabriel, Michael ;

Oberauer, Andreas ;

Dobrozemsky, Georg ;

Decristoforo, Clemens ;

Putzer, Daniel ;

Kendler, Dorota ;

Uprimny, Christian ;

Kovacs, Peter ;

Bale, Reto ;

Virgolini, Irene J. .

JOURNAL OF NUCLEAR MEDICINE, 2009, 50 (09) :1427-1434

[9] 177Lu-octreotate, alone or with radiosensitising chemotherapy, is safe in neuroendocrine tumour patients previously treated with high-activity 111In-octreotide [J].

Hubble, Daniel ;

Kong, Grace ;

Michael, Michael ;

Johnson, Val ;

Ramdave, Shakher ;

Hicks, Rodney John .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 (10) :1869-1875

[10] Response, Survival, and Long-Term Toxicity After Therapy With the Radiolabeled Somatostatin Analogue [90Y-DOTA]-TOC in Metastasized Neuroendocrine Cancers [J].

Imhof, Anna ;

Brunner, Philippe ;

Marincek, Nicolas ;

Briel, Matthias ;

Schindler, Christian ;

Rasch, Helmut ;

Maecke, Helmut R. ;

Rochlitz, Christoph ;

Mueller-Brand, Jan ;

Walter, Martin A. .

JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (17) :2416-2423

← 1 2 3 4 →